Open AccessBody Weight Change in Non-small Cell Lung Cancer Patients Treated With EGFR-TKI
Author(s) -
Takahide Kodama,
Shinya Sato,
Kunihiko Miyazaki,
Shinichiro Okauchi,
YUIKA SASATANI,
Gen Ohara,
Katsunori Kagohashi,
Hiroaki Satoh
Publication year - 2022
Publication title -
cancer diagnosis and prognosis
Language(s) - English
Resource type - Journals
ISSN - 2732-7787
DOI - 10.21873/cdp.10119
Subject(s) - medicine , lung cancer , medical record , body weight , weight loss , weight change , retrospective cohort study , tyrosine kinase inhibitor , cancer , gastroenterology , obesity
Body weight (BW) changes in epidermal growth factor inhibitor-tyrosine kinase (EGFR-TKI) treated non-small cell lung cancer patients has yet to be fully investigated. For the purpose of clarifying changes in body weight in patients who received EGFR-TKI treatment in clinical practice, we performed a retrospective study. In this study, comparison between pretreatment BW and those at 12, 24 weeks, and 12 months in these patients was performed.